Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

4.55
Delayed Data
As of May 01
 +0.26 / +6.06%
Today’s Change
1.46
Today|||52-Week Range
6.37
+187.97%
Year-to-Date

Today’s Trading

Previous close4.29
Today’s open4.33
Day’s range4.25 - 4.57
Volume275,372
Average volume (3 months)1,404,588
Market cap$163.0M
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+19.53%
Earnings growth (this year)+32.70%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.02+0.34%
PVCTProvectus Biopharmac...-0.00-0.27%
AKBAAkebia Therapeutics ...+0.18+2.35%
CORICorium International...+0.14+1.56%
Data as of 4:00pm ET, 05/01/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$29.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers